Neoadjuvant immunoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma: a retrospective study

ConclusionsNeoadjuvant nivolumab plus SBRT is safe and efficacious, and could be used as a potential neoadjuvant option for the treatment of patients with locally advanced OCSCC.

http://link.springer.com/10.1007/s10637-022-01293-9

Source: Investigational New Drugs - August 16, 2022 Category: Drugs & Pharmacology Source Type: research